Guojin Securities: Focus on the dual themes of 'innovation + overseas expansion' in medical devices; recommends prioritizing sub-sector leaders whose earnings are expected to accelerate by 2026.

The investment rationale has shifted from simple domestic substitution to two core pillars: 'innovation' and 'global expansion,' both underpinned by global competitiveness.

Zhitong FinanceJun 9 09:15

Lifetech Scientific Corporation (688016): Q1 non-GAAP net profit attributable to shareholders slightly exceeded expectations; multiple innovative products received approval for market launch.

Key View: In Q1 2026, the company's revenue and net profit attributable to shareholders grew in line with expectations, while net profit attributable to shareholders excluding non-recurring gains and losses slightly exceeded expectations. Additionally, multiple peripheral intervention products received regulatory approval in Q1, further enriching the company's peripheral product pipeline and supporting its peripheral business.

CITIC SecuritiesMay 28 14:27

Lepu Medical (688016): Strong overseas growth and expanded peripheral product sales; innovation pipeline continues to advance

The company released its first-quarter report for 2026, reporting revenue of RMB 370 million for the first quarter of 2026, an increase of 11.45% year-over-year; attributable net profit of RMB 155 million, up 19.44% year-over-year; and adjusted net profit of

Zhongtai SecuritiesMay 22 16:11

Heartbeat Medical's Shareholders' Meeting: Pre-meeting Discussions, On-site Exhibitions, and Executives Surrounded with Questions on 'Future Path'

①This hour-long discussion primarily focused on the following issues: Where is the next major product opportunity? Is there further room for price reductions for the Castor stent? How to break through the current situation? ②How to transform into a more commercially efficient and mature enterprise while maintaining its technological foundation will be the biggest highlight for this 'star of the MicroPort Group' in the next phase.

cls.cnMay 15 23:24

MicroPort MedBot Proposes New Share Scheme to Replace Existing Incentive Plans

TipRanksMay 14 21:12

MicroPort MedBot Sets 2026 AGM With New Capital Mandates on the Table

TipRanksMay 14 21:11